Independent Chairman of the Board
Mr. Jon S. Saxe J.D., is an Independent Chairman of the Board of SciClone Pharmaceuticals, Inc., since July 29, 2009. He has served as the Chairman of our Board of Directors since July 2009 and as a Director since August 2000. Mr. Saxe was President of PDL BioPharma, Inc. from 1995 to early 1999. From 1993 to 1995, Mr. Saxe was President of Saxe Associates, Inc., consultants to VC firms and biotechnology, diagnostic, and pharmaceutical companies. He was the President and CEO of Synergen, Inc., a biotechnology company acquired by Amgen, from 1989 to 1993. Mr. Saxe is former Vice President, Licensing and Corporationrationrate Development and Head of Patent Law for HoffmannLaRoche Inc., where he worked for almost 30 years
Age: 78 Chairman Since 2009
|Saxe received his B.S. Ch.E. from CarnegieMellon University, his J.D. from George Washington University School of Law and his LL.M. from New York University School of Law. He serves as a director of other public and private companies, including Durect Corporationrationration and as Chairman of VistaGen Therapeutics, Inc.|
Jon Saxe Latest Insider Trades
The company has return on total asset (ROA)
of 0.15 %
which means that it generated profit of $0.15 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of 7.9 %
meaning that it created $7.9 on every $100 dollars invested by stockholders.
The company currently holds 1.65 M in liabilities with Debt to Equity (D/E) ratio of 0.01 which may suggest the company is not taking enough advantage from borrowing. SciClone Pharmaceuticals Inc has Current Ratio of 7.33 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
SciClone Pharmaceuticals, Inc., a specialty pharmaceutical company, offer therapies for oncology, infectious diseases, and cardiovascular disorders in the People?s Republic of China, the United States, and Hong Kong. SciClone Pharmaceuticals Inc (SCLN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 590 people. SciClone Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification and specializes in Healthcare
with concentration in Pharmaceuticals And Biosciences